Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Effect of ethnicity on liver transplant for hepatocellular carcinoma.

Couto CA, Gelape CL, Calmet F, Martin P, Levy C.

Exp Clin Transplant. 2013 Aug;11(4):339-45. Erratum in: Exp Clin Transplant. 2014 Jun;12(3):281.

2.

A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma.

Hernandez-Alejandro R, Croome KP, Drage M, Sela N, Parfitt J, Chandok N, Marotta P, Dale C, Wall W, Quan D.

World J Gastroenterol. 2012 Aug 21;18(31):4145-9. doi: 10.3748/wjg.v18.i31.4145.

3.

Surgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver disease.

Wakai T, Shirai Y, Sakata J, Korita PV, Ajioka Y, Hatakeyama K.

J Gastrointest Surg. 2011 Aug;15(8):1450-8. doi: 10.1007/s11605-011-1540-8. Epub 2011 Apr 22.

PMID:
21512848
4.

Survival analysis of Hispanics in a cohort of patients with hepatocellular carcinoma.

Aparo S, Goel S, Lin D, Ohri N, Schwartz JM, Lo Y, Kaubisch A.

Cancer. 2014 Dec 1;120(23):3683-90. doi: 10.1002/cncr.28867. Epub 2014 Jul 31.

5.

Effects of ethnicity and socioeconomic status on survival and severity of fibrosis in liver transplant recipients with hepatitis C virus.

Verna EC, Valadao R, Farrand E, Pichardo EM, Lai JC, Terrault NA, Brown RS Jr.

Liver Transpl. 2012 Apr;18(4):461-7. doi: 10.1002/lt.23376.

6.

Tumor Characteristics and Long-Term Outcome of Incidental Hepatocellular Carcinoma After Orthotopic Liver Transplant.

Mourad MM, Algarni A, Aly MA, Gunson BK, Mergental H, Isaac J, Muiesan P, Mirza D, Perera MT, Bramhall SR.

Exp Clin Transplant. 2015 Aug;13(4):333-8.

7.

Liver transplantation outcomes among Caucasians, Asian Americans, and African Americans with hepatitis B.

Bzowej N, Han S, Degertekin B, Keeffe EB, Emre S, Brown R, Reddy R, Lok AS; National Institutes of Health Hepatitis B Virus Orthotopic Liver Transplantation Study Group.

Liver Transpl. 2009 Sep;15(9):1010-20. doi: 10.1002/lt.21759.

8.

Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis.

Yang D, Hanna DL, Usher J, LoCoco J, Chaudhari P, Lenz HJ, Setiawan VW, El-Khoueiry A.

Cancer. 2014 Dec 1;120(23):3707-16. doi: 10.1002/cncr.28912. Epub 2014 Jul 31.

10.

Liver transplantation in patients with hepatocellular carcinoma: a single-center experience.

Azzam AZ, Hegab B, Khalaf H, Al Bahili H, Mohammed H, Kamel Y, Abaalkhail F, Al-hamoudi W, Al Sofayan M, Al Sebayel M.

Exp Clin Transplant. 2011 Oct;9(5):323-8. Erratum in: Exp Clin Transplant. 2013 Apr;11(2):205. Abal Khail, Faisal [corrected to Abaalkhail, Faisal].

11.

Effect of steatosis donor liver transplantation on hepatocellular carcinoma recurrence: experience at a single institution.

Teng da H, Zhu ZJ, Zheng H, Deng YL, Sun LY, Pan C, Liu YH, Song HL, Shen ZY.

Hepatogastroenterology. 2012 May;59(115):858-62. doi: 10.5754/hge12007.

PMID:
22389257
12.

Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.

Reddy SK, Steel JL, Chen HW, DeMateo DJ, Cardinal J, Behari J, Humar A, Marsh JW, Geller DA, Tsung A.

Hepatology. 2012 Jun;55(6):1809-19. doi: 10.1002/hep.25536. Epub 2012 Apr 23.

PMID:
22183968
13.

Comparison of hepatitis B prophylactic outcomes in living donor liver transplantation recipients who meet the Milan or UCSF criteria.

Jiang L, Yan LN, Wen TF, Li B, Yang JY.

Hepatobiliary Pancreat Dis Int. 2013 Oct;12(5):494-9.

14.

Hepatocellular cancer: risk factors and survival in Pacific Islanders compared to Caucasians in Hawaii.

Ochner M, Wong LL, Wimmer-Kunitomo K.

Ethn Dis. 2010 Spring;20(2):169-73.

PMID:
20503898
15.

Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.

Schwartz JJ, Pappas L, Thiesset HF, Vargas G, Sorensen JB, Kim RD, Hutson WR, Boucher K, Box T.

Liver Transpl. 2012 Apr;18(4):423-33. doi: 10.1002/lt.23385.

16.

Recurrence of hepatitis C virus (genotype 4) infection after living-donor liver transplant in Egyptian patients.

Yosry A, Abdel-Rahman M, Esmat G, El-Serafy M, Omar A, Doss W, Zayed N, Said M, Ismail T, Hosny A, Marawan E, El-Malt O, Kamel RR, Hatata Y, El-Taweel A, Ghali A, Sabri H, Kamel S, El-Gabaly H.

Exp Clin Transplant. 2009 Sep;7(3):157-63.

17.

Survival in liver transplant recipients with hepatitis B- or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010.

Hu Z, Zhou J, Wang H, Zhang M, Li S, Huang Y, Wu J, Li Z, Zhou L, Zheng S.

PLoS One. 2013 Apr 16;8(4):e61620. doi: 10.1371/journal.pone.0061620. Print 2013.

18.

Post-liver transplant survival in hepatitis C patients is improving over time.

O'Leary JG, Randall H, Onaca N, Jennings L, Klintmalm GB, Davis GL.

Liver Transpl. 2009 Apr;15(4):360-8. doi: 10.1002/lt.21691.

19.

Allografts positive for hepatitis B surface antigen in liver transplant for disease related to hepatitis B virus.

Ju W, Chen M, Guo Z, Wang D, Zhu X, Huang J, He X.

Exp Clin Transplant. 2013 Jun;11(3):245-9. doi: 10.6002/ect.2012.0095. Epub 2012 Nov 20.

20.

Features and outcome after liver resection for non-B non-C hepatocellular carcinoma.

Kaneda K, Kubo S, Tanaka H, Takemura S, Ohba K, Uenishi T, Kodai S, Shinkawa H, Urata Y, Sakae M, Yamamoto T, Suehiro S.

Hepatogastroenterology. 2012 Sep;59(118):1889-92. doi: 10.5754/hge10778.

PMID:
22819910
Items per page

Supplemental Content

Write to the Help Desk